Does Vitamin D Signaling Play a Role in Keloid Pathology?
Supp, PhD1,2; Caitlin Phillips, BS2; Jane Young, BS2; Jennifer M. Hahn, BS1; Heather M. Powell, PhD3,2; Sara Higginson, MD, FACS2 Dorothy M. Supp, PhD1,2; Caitlin Phillips, BS2; Jane Young, BS2 ; Jennifer M. Hahn, BS1 ; Heather M. Powell, PhD3,2; Sara Higginson, MD, FACS2
BACKGROUND
The increased incidence of keloids in populations with dark skin pigmentation suggests a putative role for vitamin D in keloid development and/or suppression. Vitamin D is made in skin in response to sunlight, with less vitamin D made in darkly pigmented skin. Vitamin D has anti-inflammatory and anti-proliferative activities that are mediated through binding to the vitamin D receptor (VDR). Upon vitamin D binding, VDR translocates to the nucleus and binds vitamin D response elements in target genes to regulate their expression. We previously identified reduced expression and decreased nuclear localization of VDR in keloid epidermis vs. normal skin, and observed reduced VDR nuclear localization in the normal skin of non-keloid patients who self-identified as Black compared to patients who self-identified as white. Additionally, we previously reported CYP24A1 overexpression in keloids compared with normal skin. CYP24A1 encodes 24 hydroxylase, which degrades the active form of vitamin D. Our previous work found that inhibition of CYP24A1 activity in keloid-derived cells could partially normalize profibrotic gene expression. Clinical studies in several countries reported lower circulating vitamin D levels in keloid patients compared with control cohorts, but a few studies reported conflicting results. We undertook a clinical observational study to better understand the relationships among skin pigmentation, vitamin D status, race/ethnicity, and scar phenotypes in a diverse pediatric patient population.
CONCLUSION
This study found lower mean circulating vitamin D levels in keloid patients compared with non-scar patients, and lower VDR nuclear localization in keloid tissue compared with normal skin, in agreement with prior studies. Although
there were significant differences in skin pigmentation among groups when measured quantitatively, this can be explained by racial differences among groups. Further, vitamin D levels were negatively correlated with skin pigmentation, as expected, with darker skinned patients having lower vitamin D status. Therefore, while the results are consistent with prior studies, we were unable to determine whether low vitamin D status is independently associated with keloid occurrence, or whether skin pigmentation or genetic ancestry is more important.
Overall, our research suggests that vitamin D signaling may be involved in keloid pathology, although it is not yet clear whether vitamin D deficiency or low VDR levels in tissue are directly associated with risk of keloid development. However, the beneficial properties of vitamin D, and the in vitro effects previously observed with CYP24A1 inhibition, suggest a possible therapeutic role for vitamin D in keloid suppression. Future studies will investigate genomic polymorphisms related to vitamin D signaling in patients with and without keloids to determine if genetic risk factors were present in any patients in this study.
The methods, results, figures and the downloadable PDF are available to subscribers.
